Acne Treatment Pads

Manufacturer
Spa de Soleil
Effective date
2026-04-30
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:55:48

Label at a glance#

ProductAcne Treatment Pads
Active ingredientSALICYLIC ACID
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient Purpose

Salicylic Acid (0.5%)..........Acne Medication

OTC - PURPOSE SECTION

Purpose

Acne Medication

INDICATIONS & USAGE SECTION

Use for the management of acne

WARNINGS SECTION

Warnings: For external use only. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Sensitivity test for new users: Apply product sparingly to one or two small affected areas during the first three days. If no discomfort occurs, follow the steps stated in directions.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions: Cleanse the skin thoroughly before applying medication. Use the pad to wipe the entire affected area one to three times daily. . Repeat with a clean pad as necessary to remove remaining traces of dirt. . Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. .If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

INACTIVE INGREDIENT SECTION

Other ingredients: Aqua, Sodium Methyl 2-Sulfolaurate, Disodium 2-Sulfolaurate, Sodium Xylene Sulfonate, Menthol, *CO Glycerin, *CO Humulus Lupulus (Hops) Extract, *CO Lavandula Angustifolia (Lavender) Flower/Leaf/Stem Extract, *CO Calendula Officinalis Flower Extract, *CO Chamomilla Recutita (Matricaria) Flower Extract, *CO Citrus Limon (Lemon) Peel Extract, *CO Cucumis Sativus (Cucumber) Seed Extract, *CO Camellia Sinensis Leaf Extract, *CO Pyrus Malus (Apple) Fruit Extract, *CO Spirulina Platensis Extract, Disodium EDTA, Simethicone, Ethylhexylglycerin, Phenoxyethanol, Fragrance.

*CO Certified Organic

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA Acne Treatment Pads.jpgFDA Acne Treatment Pads.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68062-9004-12023-01-30C16284748780-1f386c649-e5e1-0266-e053-dadaa90a7c1aAcne Treatment Pads

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68062-9004-1Acne Treatment Pads50 mL in 1 TUBELOTION502

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68062-900468062-9004-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCERINPDC6A3C0OXIACT
MENTHOLL7T10EIP3AIACT
SALICYLIC ACIDO414PZ4LPZACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Acne Treatment PadsSALICYLIC ACIDSpa de Soleilcc0f8f77-1942-22be-e053-2a95a90a3d7f2026-04-30WarningsExact identifier
ndc (package): 68062-9004-1
ndc (product): 68062-9004
ndc11 (package): 68062900401
spl id: 50b6e826-3ec8-ee59-e063-6294a90a43eb
spl set id: cc0f8f77-1942-22be-e053-2a95a90a3d7f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.